Vaccines against monkeypox
- PMID: 37033199
- PMCID: PMC10037303
- DOI: 10.1016/j.medcle.2023.01.005
Vaccines against monkeypox
Abstract
The monkeypox virus is a virus that has 90% genomic homology with the human (smallpox), but it is naturally transmitted between different wild animal reservoirs and is considered a zoonosis. Throughout the 20th century, different vaccines based on the vaccinia poxvirus were developed and used for vaccination against smallpox. After the eradication of smallpox, these vaccines were no longer used. Current vaccines against monkeypox virus are classified by the WHO as replicative (ACAM2000), minimally replicative (LC16m8) and non-replicative (MVA-BN), the latter being the one currently used. The 2022 extra-African monkeypox virus epidemic has highlighted the lack of vaccines with proven efficacy and low reactogenicity. It is considered that the use of this vaccine in the current outbreak may play a role in the prevention or attenuation of the disease as pre-exposure prophylaxis in close contacts of confirmed cases.
El virus de la viruela de los monos es un virus que presenta un 90% de homología genómica con el humano (smallpox), pero se trasmite de forma natural entre diferentes reservorios animales salvajes y es considerado una zoonosis. A lo largo del siglo XX se desarrollaron diferentes vacunas basadas en el poxvirus vaccinia que fueron utilizadas para la vacunación frente a la viruela humana. Tras la erradicación de la viruela humana estas vacunas dejaron de utilizarse. Las vacunas actuales frente a la viruela de los monos se clasifican por la OMS como replicativas (ACAM2000), mínimamente replicativas (LC16m8) y no replicativas (MVA-BN), siendo esta última la utilizada en la actualidad. La epidemia extraafricana de viruela de los monos de 2022 ha puesto en evidencia la falta de vacunas de eficacia demostrada y de baja reactogenicidad. Se considera que la utilización de esta vacuna en el brote actual puede desempeñar un papel en la prevención o atenuación de la enfermedad como profilaxis preexposición en contactos estrechos de casos confirmados.
Keywords: Monkeypox virus; Vaccination; Vaccines.
© 2023 Elsevier España, S.L.U. All rights reserved.
Figures
Similar articles
-
Vaccines against monkeypox.Med Clin (Barc). 2023 Apr 6;160(7):305-309. doi: 10.1016/j.medcli.2023.01.001. Epub 2023 Feb 10. Med Clin (Barc). 2023. PMID: 36775782 Free PMC article. Review. English, Spanish.
-
Poxvirus Vaccines: Past, Present, and Future.Adv Exp Med Biol. 2024;1451:273-287. doi: 10.1007/978-3-031-57165-7_17. Adv Exp Med Biol. 2024. PMID: 38801584 Review.
-
Progress and prospects on vaccine development against monkeypox infection.Microb Pathog. 2023 Jul;180:106156. doi: 10.1016/j.micpath.2023.106156. Epub 2023 May 16. Microb Pathog. 2023. PMID: 37201635 Free PMC article. Review.
-
Efficacy and Safety of the Smallpox Vaccine for Postexposure Prophylaxis in Monkeypox: Protocol for an Open-Labeled, Single-Armed Study.JMIR Res Protoc. 2023 Aug 25;12:e46955. doi: 10.2196/46955. JMIR Res Protoc. 2023. PMID: 37624623 Free PMC article.
-
The Global Monkeypox (Mpox) Outbreak: A Comprehensive Review.Vaccines (Basel). 2023 Jun 12;11(6):1093. doi: 10.3390/vaccines11061093. Vaccines (Basel). 2023. PMID: 37376482 Free PMC article. Review.
Cited by
-
Exploring monkeypox virus antibody levels: insights from human immunological research.Virol J. 2025 May 31;22(1):175. doi: 10.1186/s12985-025-02748-0. Virol J. 2025. PMID: 40450351 Free PMC article. Review.
-
Pharmacological treatment and vaccines in monkeypox virus: a narrative review and bibliometric analysis.Front Pharmacol. 2023 May 5;14:1149909. doi: 10.3389/fphar.2023.1149909. eCollection 2023. Front Pharmacol. 2023. PMID: 37214444 Free PMC article. Review.
-
Global epidemiology, viral evolution, and public health responses: a systematic review on Mpox (1958-2024).J Glob Health. 2025 Mar 7;15:04061. doi: 10.7189/jogh.15.04061. J Glob Health. 2025. PMID: 40048320 Free PMC article.
-
Antigen recognition and immune response to monkeypox virus infection: implications for Mpox vaccine design - a narrative review.Infez Med. 2025 Jun 1;33(2):151-162. doi: 10.53854/liim-3302-1. eCollection 2025. Infez Med. 2025. PMID: 40519344 Free PMC article. Review.
-
Construction of a recombinant vaccine expressing Nipah virus glycoprotein using the replicative and highly attenuated vaccinia virus strain LC16m8.PLoS Negl Trop Dis. 2023 Dec 15;17(12):e0011851. doi: 10.1371/journal.pntd.0011851. eCollection 2023 Dec. PLoS Negl Trop Dis. 2023. PMID: 38100536 Free PMC article.
References
-
- Jezek Z., Fenner F. Human monkeypox. Monogr Virol. 1988;17:1–40.
-
- McCollum A.M., Damon I.K. Human monkeypox. Clin Infect Dis. 2014;58:260–267. - PubMed
-
- Reina J., Reina N. ¿Deberíamos empezar a preocuparnos por la viruela del mono? Med Clin (Barc) 2018;151:320–322. - PubMed
-
- Reed K.D., Melski J.W., Craham M.B., Regnery T.L., Sotir M.J., Wegner M.V., et al. The detection of monkeypox in humans in the Western Hemisphere. N Engl J Med. 2004;350:342–350. - PubMed
Publication types
LinkOut - more resources
Full Text Sources